Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2025 Filed Mar 4, 2025 23:41 UTC |
Smith Kevin Raymond MerrillDirector · CEO and President
|
GrantCommon Stock | 53,975 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-032638 · ownership.xml · nonDerivative · entry 4 Smith Kevin Raymond Merrill · CIK 0001802639 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 84,662 F3 · shares: The reported securities represent shares earned and vested on March 1, 2025 based on achievement of the financial performance conditions for the 2024 fiscal year that were approved as part of the 2023 performance-based restricted stock unit award granted on November 10, 2023. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 23:41 UTC |
Smith Kevin Raymond MerrillDirector · CEO and President
|
Tax withholdingCommon Stock | 13,700 | $8.33 | $114,121.00 |
DisclosureSEC source: 0000950170-25-032638 · ownership.xml · nonDerivative · entry 3 Smith Kevin Raymond Merrill · CIK 0001802639 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,687 F2 · shares: The reported shares were withheld to cover the reporting person's tax withholding liability in connection with a portion of a time-based restricted stock unit award that vested on March 1, 2025. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 23:41 UTC |
Smith Kevin Raymond MerrillDirector · CEO and President
|
Exercise / conversionCommon Stock | 28,333 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-032638 · ownership.xml · nonDerivative · entry 2 Smith Kevin Raymond Merrill · CIK 0001802639 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,387 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 23:41 UTC |
Smith Kevin Raymond MerrillDirector · CEO and President
|
GrantCommon Stock | 1,500 | $8.33 | $12,495.00 |
DisclosureSEC source: 0000950170-25-032638 · ownership.xml · nonDerivative · entry 1 Smith Kevin Raymond Merrill · CIK 0001802639 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,054 F1 · shares: Shares acquired through the Company's 2014 Employee Stock Purchase Plan. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 18:43 UTC |
Smith Kevin P.EVP, Bus Dev, GC & Sec
|
GrantRestricted Stock Unit · Derivative | 42,016 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-032643 · ownership.xml · derivative · entry 2 Smith Kevin P. · CIK 0002031211 · EVP, Bus Dev, GC & Sec 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,016 Underlying: Common Stock · 42,016 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F3 · derivative.exercise_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2026 (the "Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date. F3 · derivative.expiration_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2026 (the "Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 23:44 UTC |
Ramade GregoireChief Commercial Officer
|
GrantRestricted Stock Unit · Derivative | 39,015 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-032645 · ownership.xml · derivative · entry 1 Ramade Gregoire · CIK 0001752887 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 39,015 Underlying: Common Stock · 39,015 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F2 · derivative.exercise_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2026 (the "Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date. F2 · derivative.expiration_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2026 (the "Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 23:42 UTC |
Bourque Michael J.EVP, CFO & Treasurer
|
GrantRestricted Stock Unit · Derivative | 51,020 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-032642 · ownership.xml · derivative · entry 7 Bourque Michael J. · CIK 0001638420 · EVP, CFO & Treasurer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 51,020 Underlying: Common Stock · 51,020 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F6 · derivative.exercise_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2026 (the "Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date. F6 · derivative.expiration_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2026 (the "Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 23:41 UTC |
Smith Kevin Raymond MerrillDirector · CEO and President
|
GrantRestricted Stock Unit · Derivative | 90,036 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-032638 · ownership.xml · derivative · entry 7 Smith Kevin Raymond Merrill · CIK 0001802639 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 90,036 Underlying: Common Stock · 90,036 shares Expires not disclosed F6 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F7 · derivative.exercise_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2026 (the "Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date. F7 · derivative.expiration_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2026 (the "Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 17:11 UTC |
Sahney Mira KirtiDirector
|
GrantCommon Stock | 9,112 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-013698 · ownership.xml · nonDerivative · entry 1 Sahney Mira Kirti · CIK 0002054249 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,112 F1 · shares: The reported shares were acquired pursuant to a restricted stock unit award. The award will vest on May 14, 2025, which is the same date as other non-employee director awards issued by Inogen that were outstanding as of the grant date, subject to the reporting person continuing to serve as a director through the vesting date. Read SEC document |
| December 01, 2024 Filed Dec 3, 2024 22:05 UTC |
Ramade GregoireChief Commercial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 31,565 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-132856 · ownership.xml · derivative · entry 3 Ramade Gregoire · CIK 0001752887 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,131 Underlying: Common Stock · 31,565 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F3 · derivative.exercise_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest one year from December 1, 2023 (the "Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date. F3 · derivative.expiration_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest one year from December 1, 2023 (the "Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date. Read SEC document |
| December 01, 2024 Filed Dec 3, 2024 22:05 UTC |
Ramade GregoireChief Commercial Officer
|
Tax withholdingCommon Stock | 12,942 | $9.71 | $125,666.82 |
DisclosureSEC source: 0000950170-24-132856 · ownership.xml · nonDerivative · entry 2 Ramade Gregoire · CIK 0001752887 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,623 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on December 1, 2024. Read SEC document |
| December 01, 2024 Filed Dec 3, 2024 22:05 UTC |
Ramade GregoireChief Commercial Officer
|
Exercise / conversionCommon Stock | 31,565 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-132856 · ownership.xml · nonDerivative · entry 1 Ramade Gregoire · CIK 0001752887 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,565 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2024 Filed Dec 3, 2024 22:08 UTC |
Smith Kevin Raymond MerrillDirector · CEO and President
|
Exercise / conversionRestricted Stock Unit · Derivative | 28,333 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-132860 · ownership.xml · derivative · entry 3 Smith Kevin Raymond Merrill · CIK 0001802639 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,667 Underlying: Common Stock · 28,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F3 · derivative.exercise_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest one year from December 1, 2023 (the "Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date. F3 · derivative.expiration_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest one year from December 1, 2023 (the "Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date. Read SEC document |
| December 01, 2024 Filed Dec 3, 2024 22:08 UTC |
Smith Kevin Raymond MerrillDirector · CEO and President
|
Tax withholdingCommon Stock | 13,779 | $9.71 | $133,794.09 |
DisclosureSEC source: 0000950170-24-132860 · ownership.xml · nonDerivative · entry 2 Smith Kevin Raymond Merrill · CIK 0001802639 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,554 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on December 1, 2024. Read SEC document |
| December 01, 2024 Filed Dec 3, 2024 22:08 UTC |
Smith Kevin Raymond MerrillDirector · CEO and President
|
Exercise / conversionCommon Stock | 28,333 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-132860 · ownership.xml · nonDerivative · entry 1 Smith Kevin Raymond Merrill · CIK 0001802639 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,333 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 22, 2024 Filed Jul 24, 2024 19:45 UTC |
Smith Kevin P.EVP, Bus Dev, GC & Sec
|
GrantRestricted Stock Unit · Derivative | 54,406 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-086207 · ownership.xml · derivative · entry 1 Smith Kevin P. · CIK 0002031211 · EVP, Bus Dev, GC & Sec 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,406 Underlying: Common Stock · 54,406 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F2 · derivative.exercise_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest one year from September 1, 2024 (the "Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date. F2 · derivative.expiration_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest one year from September 1, 2024 (the "Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 17:21 UTC |
Boehnlein Glenn SDirector
|
GrantCommon Stock | 21,871 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-070904 · ownership.xml · nonDerivative · entry 1 Boehnlein Glenn S · CIK 0001670936 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,273 F1 · shares: The reported shares wee acquired pursuant to a restricted stock unit award, which shall vest on the earlier of (i) the one-year anniversary of the date of grant or (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date of grant, in each case, subject to the reporting person continuing to be a service provider through the applicable vesting schedule. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 21:18 UTC |
West Thomas A.Director
|
GrantCommon Stock | 21,871 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-070890 · ownership.xml · nonDerivative · entry 1 West Thomas A. · CIK 0001620705 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,677 F1 · shares: The reported shares wee acquired pursuant to a restricted stock unit award, which shall vest on the earlier of (i) the one-year anniversary of the date of grant or (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date of grant, in each case, subject to the reporting person continuing to be a service provider through the applicable vesting schedule. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 21:44 UTC |
Rider Heather D.Director
|
GrantCommon Stock | 21,871 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-070932 · ownership.xml · nonDerivative · entry 1 Rider Heather D. · CIK 0001616363 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,589 F1 · shares: The reported shares wee acquired pursuant to a restricted stock unit award, which shall vest on the earlier of (i) the one-year anniversary of the date of grant or (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date of grant, in each case, subject to the reporting person continuing to be a service provider through the applicable vesting schedule. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 21:23 UTC |
Mora ElizabethDirector
|
GrantCommon Stock | 21,871 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-070911 · ownership.xml · nonDerivative · entry 1 Mora Elizabeth · CIK 0001548935 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,568 F1 · shares: The reported shares wee acquired pursuant to a restricted stock unit award, which shall vest on the earlier of (i) the one-year anniversary of the date of grant or (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date of grant, in each case, subject to the reporting person continuing to be a service provider through the applicable vesting schedule. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 21:20 UTC |
King Kevin MDirector
|
GrantCommon Stock | 21,871 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-070902 · ownership.xml · nonDerivative · entry 1 King Kevin M · CIK 0001385014 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,273 F1 · shares: The reported shares wee acquired pursuant to a restricted stock unit award, which shall vest on the earlier of (i) the one-year anniversary of the date of grant or (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date of grant, in each case, subject to the reporting person continuing to be a service provider through the applicable vesting schedule. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 21:16 UTC |
Ladone Mary KayDirector
|
GrantCommon Stock | 21,871 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-070879 · ownership.xml · nonDerivative · entry 1 Ladone Mary Kay · CIK 0001760737 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,273 F1 · shares: The reported shares wee acquired pursuant to a restricted stock unit award, which shall vest on the earlier of (i) the one-year anniversary of the date of grant or (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date of grant, in each case, subject to the reporting person continuing to be a service provider through the applicable vesting schedule. Read SEC document |
| June 01, 2024 Filed Jun 4, 2024 21:08 UTC |
Somer JasonEVP, Gen. Counsel & Secretary
|
Exercise / conversionRestricted Stock Unit · Derivative | 577 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-068828 · ownership.xml · derivative · entry 3 Somer Jason · CIK 0001868735 · EVP, Gen. Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,882 Underlying: Common Stock · 577 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F3 · derivative.exercise_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on September 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month. F3 · derivative.expiration_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on September 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month. Read SEC document |
| June 01, 2024 Filed Jun 4, 2024 21:08 UTC |
Somer JasonEVP, Gen. Counsel & Secretary
|
Tax withholdingCommon Stock | 339 | $8.30 | $2,813.70 |
DisclosureSEC source: 0000950170-24-068828 · ownership.xml · nonDerivative · entry 2 Somer Jason · CIK 0001868735 · EVP, Gen. Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,690 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on June 1, 2024. Read SEC document |
| June 01, 2024 Filed Jun 4, 2024 21:08 UTC |
Somer JasonEVP, Gen. Counsel & Secretary
|
Exercise / conversionCommon Stock | 577 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-068828 · ownership.xml · nonDerivative · entry 1 Somer Jason · CIK 0001868735 · EVP, Gen. Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,029 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2024 Filed May 14, 2024 22:43 UTC |
Somer JasonEVP, Gen. Counsel & Secretary
|
SaleCommon Stock | 10,000 | $8.56 | $85,600.00 |
DisclosureSEC source: 0000950170-24-059880 · ownership.xml · nonDerivative · entry 1 Somer Jason · CIK 0001868735 · EVP, Gen. Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,452 F1 · price: Represents the weighted average share price of an aggregate total of 10,000 shares sold in the price range of $8.41 to $8.73 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 01, 2024 Filed May 3, 2024 22:15 UTC |
Somer JasonEVP, Gen. Counsel & Secretary
|
Exercise / conversionRestricted Stock Unit · Derivative | 19,276 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-053102 · ownership.xml · derivative · entry 3 Somer Jason · CIK 0001868735 · EVP, Gen. Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,276 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F3 · derivative.exercise_date: Subject to the reporting person's continued service, one hundred percent (100%) of the restricted stock units shall vest on May 1, 2024. F3 · derivative.expiration_date: Subject to the reporting person's continued service, one hundred percent (100%) of the restricted stock units shall vest on May 1, 2024. Read SEC document |
| May 01, 2024 Filed May 3, 2024 22:15 UTC |
Somer JasonEVP, Gen. Counsel & Secretary
|
Tax withholdingCommon Stock | 11,312 | $7.05 | $79,749.60 |
DisclosureSEC source: 0000950170-24-053102 · ownership.xml · nonDerivative · entry 2 Somer Jason · CIK 0001868735 · EVP, Gen. Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,452 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on May 1, 2024. Read SEC document |
| May 01, 2024 Filed May 3, 2024 22:15 UTC |
Somer JasonEVP, Gen. Counsel & Secretary
|
Exercise / conversionCommon Stock | 19,276 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-053102 · ownership.xml · nonDerivative · entry 1 Somer Jason · CIK 0001868735 · EVP, Gen. Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,764 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2024 Filed May 3, 2024 22:14 UTC |
Glezer StanislavEVP, R&D & Chief Med. Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 32,638 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-053100 · ownership.xml · derivative · entry 3 Glezer Stanislav · CIK 0001866861 · EVP, R&D & Chief Med. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 32,638 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F3 · derivative.exercise_date: Subject to the reporting person's continued service, one hundred percent (100%) of the restricted stock units shall vest on May 1, 2024 F3 · derivative.expiration_date: Subject to the reporting person's continued service, one hundred percent (100%) of the restricted stock units shall vest on May 1, 2024 Read SEC document |
| May 01, 2024 Filed May 3, 2024 22:14 UTC |
Glezer StanislavEVP, R&D & Chief Med. Officer
|
Tax withholdingCommon Stock | 16,695 | $7.05 | $117,699.75 |
DisclosureSEC source: 0000950170-24-053100 · ownership.xml · nonDerivative · entry 2 Glezer Stanislav · CIK 0001866861 · EVP, R&D & Chief Med. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,049 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on May 1, 2024. Read SEC document |
| May 01, 2024 Filed May 3, 2024 22:14 UTC |
Glezer StanislavEVP, R&D & Chief Med. Officer
|
Exercise / conversionCommon Stock | 32,638 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-053100 · ownership.xml · nonDerivative · entry 1 Glezer Stanislav · CIK 0001866861 · EVP, R&D & Chief Med. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,744 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 04, 2024 Filed Mar 7, 2024 01:46 UTC |
Bourque Michael J.EVP, CFO & Treasurer
|
GrantRestricted Stock Unit · Derivative | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-027519 · ownership.xml · derivative · entry 1 Bourque Michael J. · CIK 0001638420 · EVP, CFO & Treasurer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F2 · derivative.exercise_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest one year from March 1, 2024 (the "Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date. F2 · derivative.expiration_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest one year from March 1, 2024 (the "Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 00:10 UTC |
Somer JasonEVP, Gen. Counsel & Secretary
|
GrantRestricted Stock Unit · Derivative | 21,996 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-026543 · ownership.xml · derivative · entry 6 Somer Jason · CIK 0001868735 · EVP, Gen. Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,996 Underlying: Common Stock · 21,996 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F6 · derivative.exercise_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2025, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date. F6 · derivative.expiration_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2025, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 00:10 UTC |
Somer JasonEVP, Gen. Counsel & Secretary
|
Exercise / conversionRestricted Stock Unit · Derivative | 4,680 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-026543 · ownership.xml · derivative · entry 5 Somer Jason · CIK 0001868735 · EVP, Gen. Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,359 Underlying: Common Stock · 4,680 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F5 · derivative.exercise_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2024, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date. F5 · derivative.expiration_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2024, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 00:10 UTC |
Somer JasonEVP, Gen. Counsel & Secretary
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,894 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-026543 · ownership.xml · derivative · entry 4 Somer Jason · CIK 0001868735 · EVP, Gen. Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,893 Underlying: Common Stock · 1,894 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F4 · derivative.exercise_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2023, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date. F4 · derivative.expiration_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2023, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 00:10 UTC |
Somer JasonEVP, Gen. Counsel & Secretary
|
Exercise / conversionRestricted Stock Unit · Derivative | 576 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-026543 · ownership.xml · derivative · entry 3 Somer Jason · CIK 0001868735 · EVP, Gen. Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,459 Underlying: Common Stock · 576 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F3 · derivative.exercise_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on September 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month. F3 · derivative.expiration_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on September 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 00:10 UTC |
Somer JasonEVP, Gen. Counsel & Secretary
|
Tax withholdingCommon Stock | 4,576 | $7.03 | $32,146.40 |
DisclosureSEC source: 0000950170-24-026543 · ownership.xml · nonDerivative · entry 2 Somer Jason · CIK 0001868735 · EVP, Gen. Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,488 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on March 1, 2024. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 00:10 UTC |
Somer JasonEVP, Gen. Counsel & Secretary
|
Exercise / conversionCommon Stock | 7,150 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-026543 · ownership.xml · nonDerivative · entry 1 Somer Jason · CIK 0001868735 · EVP, Gen. Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,064 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 00:09 UTC |
Smith Kevin Raymond MerrillDirector · CEO and President
|
GrantRestricted Stock Unit · Derivative | 85,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-026542 · ownership.xml · derivative · entry 1 Smith Kevin Raymond Merrill · CIK 0001802639 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,000 Underlying: Common Stock · 85,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F2 · derivative.exercise_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2025, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date. F2 · derivative.expiration_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2025, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 00:08 UTC |
Glezer StanislavEVP, R&D & Chief Med. Officer
|
GrantRestricted Stock Unit · Derivative | 43,993 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-026541 · ownership.xml · derivative · entry 6 Glezer Stanislav · CIK 0001866861 · EVP, R&D & Chief Med. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,993 Underlying: Common Stock · 43,993 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F6 · derivative.exercise_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2025, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date. F6 · derivative.expiration_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2025, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 00:08 UTC |
Glezer StanislavEVP, R&D & Chief Med. Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 9,360 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-026541 · ownership.xml · derivative · entry 5 Glezer Stanislav · CIK 0001866861 · EVP, R&D & Chief Med. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,719 Underlying: Common Stock · 9,360 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F5 · derivative.exercise_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2024, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date. F5 · derivative.expiration_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2024, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 00:08 UTC |
Glezer StanislavEVP, R&D & Chief Med. Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 3,786 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-026541 · ownership.xml · derivative · entry 4 Glezer Stanislav · CIK 0001866861 · EVP, R&D & Chief Med. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,787 Underlying: Common Stock · 3,786 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F4 · derivative.exercise_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2023, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date. F4 · derivative.expiration_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2023, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 00:08 UTC |
Glezer StanislavEVP, R&D & Chief Med. Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 768 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-026541 · ownership.xml · derivative · entry 3 Glezer Stanislav · CIK 0001866861 · EVP, R&D & Chief Med. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,612 Underlying: Common Stock · 768 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F3 · derivative.exercise_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on September 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month. F3 · derivative.expiration_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on September 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 00:08 UTC |
Glezer StanislavEVP, R&D & Chief Med. Officer
|
Tax withholdingCommon Stock | 7,623 | $7.03 | $53,551.58 |
DisclosureSEC source: 0000950170-24-026541 · ownership.xml · nonDerivative · entry 2 Glezer Stanislav · CIK 0001866861 · EVP, R&D & Chief Med. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,106 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on March 1, 2024. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 00:08 UTC |
Glezer StanislavEVP, R&D & Chief Med. Officer
|
Exercise / conversionCommon Stock | 13,914 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-026541 · ownership.xml · nonDerivative · entry 1 Glezer Stanislav · CIK 0001866861 · EVP, R&D & Chief Med. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,729 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2023 Filed Dec 4, 2023 23:30 UTC |
Somer JasonEVP, Gen. Counsel & Secretary
|
Exercise / conversionRestricted Stock Unit · Derivative | 576 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-057305 · doc4.xml · derivative · entry 3 Somer Jason · CIK 0001868735 · EVP, Gen. Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,035 Underlying: Common Stock · 576 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F3 · derivative.exercise_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on September 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month. F3 · derivative.expiration_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on September 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month. Read SEC document |
| December 01, 2023 Filed Dec 4, 2023 23:30 UTC |
Somer JasonEVP, Gen. Counsel & Secretary
|
Tax withholdingCommon Stock | 286 | $5.72 | $1,635.92 |
DisclosureSEC source: 0001209191-23-057305 · doc4.xml · nonDerivative · entry 2 Somer Jason · CIK 0001868735 · EVP, Gen. Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,914 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on December 1, 2023. Read SEC document |
| December 01, 2023 Filed Dec 4, 2023 23:30 UTC |
Somer JasonEVP, Gen. Counsel & Secretary
|
Exercise / conversionCommon Stock | 576 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-057305 · doc4.xml · nonDerivative · entry 1 Somer Jason · CIK 0001868735 · EVP, Gen. Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2023 Filed Dec 4, 2023 23:29 UTC |
Glezer StanislavEVP, Chief Technology Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 3,786 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-057302 · doc4.xml · derivative · entry 4 Glezer Stanislav · CIK 0001866861 · EVP, Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,787 Underlying: Common Stock · 3,786 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F4 · derivative.exercise_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on December 1, 2022, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the vesting commencement date. F4 · derivative.expiration_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on December 1, 2022, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the vesting commencement date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.